HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA

Regulation of Multidrug Resistance Protein 1 by Tumor Necrosis Factor   in Cultured Glial Cells: Involvement of Nuclear Factor- B and c-Jun N-Terminal Kinase Signaling Pathways

(2010) P. T. Ronaldson et al.   MOLECULAR PHARMACOLOGY

The Role of Neuroimmunomodulation in Alzheimer's Disease

(2009) Ricardo B. Maccioni et al.   Annals of the New York Academy of Sciences

Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes

(2009) Wendy L. Thompson et al.   BRAIN RESEARCH

Dopaminergic neurotoxicity of HIV-1 gp120: Reactive oxygen species as signaling intermediates

(2009) Lokesh Agrawal et al.   BRAIN RESEARCH

HIV-1 gp120-induced neuroinflammation: Relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes

(2009) Jean-Pierre Louboutin et al.   EXPERIMENTAL NEUROLOGY

Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders

(2009) Dawn Eggert et al.   JOURNAL OF NEUROIMMUNOLOGY

Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter and microRNA Regulation for Cancer Therapy

(2009) Chunxiao Wu et al.   MOLECULAR THERAPY

Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells

(2009) Peter G. Hawkins et al.   NUCLEIC ACIDS RESEARCH

Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection

(2009) George Sellhorn et al.   VACCINE

Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice

(2008) X. Zhang et al.   INFLAMMATION RESEARCH

HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells

(2008) Patrick T. Ronaldson et al.   JOURNAL OF NEUROCHEMISTRY

Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection

(2008) D. N. Sather et al.   JOURNAL OF VIROLOGY